Skip to main content
Premium Trial:

Request an Annual Quote

You'd Think That Could Be Pooled into a Decent Clinical Trial

Over at Patent Docs, Donald Zuhn rounds up the money spent by pharma/biotech organizations to lobby the US federal government in the first quarter of this year. PhRMA tops the list with $3.6 million, while Pfizer and Amgen came in with a respectable $2.8 million and $2.5 million, respectively. It turns out that if you want to be properly schmoozed, you shouldn't spend time with Biogen -- that company only spent $200,000 to influence government. The post also includes an early look at second-quarter lobbying expenditures, indicating that many organizations are plowing even more funds into the effort.

 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.